Bulletin
Investor Alert

New York Markets Open in:

Lipocine Inc.

NAS: LPCN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 15, 2022, 7:04 p.m.

/zigman2/quotes/202742746/composite

$

0.71

Change

+0.0074 +1.05%

Volume

Volume 8,588

Quotes are delayed by 20 min

/zigman2/quotes/202742746/composite

Previous close

$ 0.71

$ 0.70

Change

-0.0012 -0.17%

Day low

Day high

$0.70

$0.73

Open

52 week low

52 week high

$0.70

$1.89

Open

Insider Actions for Lipocine Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/17/2022 Krista Fogarty
Principal Accounting Officer
12,500   Acquisition at $0.86 per share. 10,750
05/16/2022 Mahesh V. Patel
CEO and President; Director
50,000   Acquisition at $0.77 per share. 38,500
11/18/2021 Mahesh V. Patel
CEO and President; Director
25,000   Acquisition at $1.09 per share. 27,250
12/31/2020 John W. Higuchi
Director
5,000   Disposition at $1.35 per share. 6,750
12/31/2020 John W. Higuchi
Director
1,700   Disposition at $1.34 per share. 2,278
12/16/2020 Mahesh V. Patel
CEO and President; Director
15,000   Disposition at $1.35 per share. 20,250
12/16/2020 Morgan R. Brown
EVP and CFO
8,437   Disposition at $1.35 per share. 11,389
12/16/2020 Mahesh V. Patel
CEO and President; Director
45,000   Derivative/Non-derivative trans. at $0 per share. 0
12/16/2020 John W. Higuchi
Director
3,750   Derivative/Non-derivative trans. at $0 per share. 0
12/16/2020 Morgan R. Brown
EVP and CFO
28,125   Derivative/Non-derivative trans. at $0 per share. 0
12/16/2020 Stephen Anthony Hill
Director
7,500   Derivative/Non-derivative trans. at $0 per share. 0
12/16/2020 Richard Dana Ono
Director
5,250   Derivative/Non-derivative trans. at $0 per share. 0
12/16/2020 Jeffrey Arvin Fink
Director
5,625   Derivative/Non-derivative trans. at $0 per share. 0
12/05/2020 Mahesh V. Patel
CEO and President; Director
122,978   Derivative/Non-derivative trans. at $0 per share. 0
12/05/2020 Morgan R. Brown
EVP and CFO
70,754   Derivative/Non-derivative trans. at $0 per share. 0
12/04/2020 Mahesh V. Patel
CEO and President; Director
43,500   Disposition at $1.57 per share. 68,295
12/04/2020 Morgan R. Brown
EVP and CFO
17,250   Disposition at $1.57 per share. 27,082
12/04/2020 Mahesh V. Patel
CEO and President; Director
145,000   Derivative/Non-derivative trans. at $0 per share. 0
12/04/2020 Morgan R. Brown
EVP and CFO
57,500   Derivative/Non-derivative trans. at $0 per share. 0
03/17/2020 John W. Higuchi
Director
220,000   Acquisition at $0.32 per share. 70,400
12/31/2019 Mahesh V. Patel
CEO and President; Director
40,000   Acquisition at $0.38 per share. 15,200
12/10/2019 Mahesh V. Patel
CEO and President; Director
25,000   Acquisition at $0.4 per share. 10,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
0 Sales
12,500
0
Last 6 months
2 Purchases
0 Sales
62,500
0
Last 12 months
3 Purchases
0 Sales
87,500
0

Officers and Executives

Dr. Mahesh V. Patel
Chairman, President, Chief Executive Officer & CFO
Dr. Anthony DelConte
Chief Medical Director
Dr. Nachiappan Chidambaram
Vice President-Product Development
Mr. John W. Higuchi
Director
Ms. Krista Fogarty
Chief Accounting Officer
Mr. Hans Vitzthum
Head-Investors Relation Contact
Dr. Jill M. Jene
Independent Director
Dr. Spyros Papapetropoulos
Independent Director
Dr. Richard Dana Ono
Independent Director
Mr. Jeffrey Arvin Fink
Independent Director
Link to MarketWatch's Slice.